Innovative Cellular Therapeutics, Inc.
H‑1B Sponsor Verified
Yes. Innovative Cellular Therapeutics, Inc. filed 12 H-1B labor condition applications (LCAs) with the U.S. Department of Labor from 2022–2025, including 3 in 2025. The average H-1B salary is $81,542 and the most sponsored role is Quality Control Manager.
Source: U.S. Department of Labor LCA disclosure data. Most recent filing on record: Jul 14, 2025.
LinkedIn ↗Latest Year Filings
3
In 2025
↗ Filter by year
Total H‑1B Filings
12
Since 2020
↗ View records
Avg Annual Salary
$81,542
All years combined
↗ View chart
Top Role
Quality Control Manager
↗ Click to filter
Filing trend
H‑1B filings by year for Innovative Cellular Therapeutics, Inc.
| Year | LCA filings | Avg salary |
|---|---|---|
| 2025 | 3 | $105,935 |
| 2024 | 6 | $76,919 |
| 2023 | 2 | $70,730 |
| 2022 | 1 | $57,720 |
Click a bar to filter records
Yearly filings & average salary · swipe to explore
SponsorStats AI
Summary